The Efficacy and Safety of Once-Weekly, Subcutaneous Dulaglutide Monotherapy Compared to Glimepiride in Patients With Type 2 Diabetes Mellitus
Phase of Trial: Phase III
Latest Information Update: 06 Dec 2017
At a glance
- Drugs Dulaglutide (Primary) ; Glimepiride
- Indications Type 2 diabetes mellitus
- Focus Registrational; Therapeutic Use
- Sponsors Eli Lilly
- 10 Jun 2017 Biomarkers information updated
- 22 Aug 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 31 Mar 2014 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.